MEDNAX, Inc. (NYSE:MD) Q2 2020 Earnings Conference Call - Final Transcript

Jul 30, 2020 • 10:00 am ET


MEDNAX, Inc. (NYSE:MD) Q2 2020 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Ladies and gentlemen, thank you for standing by. Welcome to the MEDNAX, Inc. Second Quarter 2020 Earnings Call. [Operator Instructions]

I would now like to turn the conference over to our host, Charles Lynch. Please go ahead.

Charles Lynch

Thank you, operator, and good morning, everyone. Joining me today for our call are our Chief Executive Officer, Mark Ordan; our Chief Financial Officer, Stephen Farber; and President of Pediatrics and Obstetrics Medical Group, Dr. Mack Hinson. I'll quickly read our forward-looking statements and then turn the call over to Mark. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by MEDNAX's management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today.

And MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company's most recent annual report on Form 10-K, its quarterly reports on Form 10-Q and its current reports on Form 8-K, including the sections entitled Risk Factors. In today's remarks by management, we will be discussing non-GAAP financial metrics. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be found in this morning's earnings press release, our annual report on Form 10-K and in the Investors section of our website located at With that, I'll turn the call over to Mark.

Mark S. Ordan

Thanks, Charlie. Good morning, everyone, and thanks for joining our call. I'm excited to join MEDNAX and to support this great national medical and healthcare group. Over the past several weeks, I've spent in time meeting with people across the organization, including practice groups in both pediatrics and radiology, and I've been so impressed with the dedication it clearly has to this company's decade long mission, to take great care of the patient. As you know, MEDNAX has always been physician-led at the top of the organization. That will continue, and that's why Dr. Mack Hinson is here with us today. In particular, I want to thank Roger Medel, both for his gracious introduction to the MEDNAX team and to help me get up to speed. Dr. Medel made this a physician- and patient-centric culture, and that has been key to MEDNAX' success and longevity. MEDNAX' strong mission and spirit spring from Dr. Medel's determination and care. I want to assure you that MEDNAX mission will not change.

Even as we continue to address an unprecedented pandemic across the country, the care the clinicians across our organization provide every day is as important as ever. And the focus that MEDNAX has always shown over the year